# Crisugabalin in NMOSD Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Exploratory Trial

> **NCT07699770** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Tang-Du Hospital** · enrollment: 110 (estimated)

## Conditions studied

- Neuromyelitis Optica Spectrum Disorders (NMOSD)
- Neuropathic Pain

## Interventions

- **DRUG:** Crisugabalin
- **DRUG:** Placebo+Crisugabalin

## Key facts

- **NCT ID:** NCT07699770
- **Lead sponsor:** Tang-Du Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-15
- **Primary completion:** 2027-10-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2026-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07699770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07699770, "Crisugabalin in NMOSD Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Exploratory Trial". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07699770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*